Document sharing
Users can share documents within teams and set simple access, but there is no advanced foldering or document grouping for large archives.
Pharmaceutical teams often outgrow SignaShare when they require advanced field automation, comprehensive regulatory compliance, mobile signing, or streamlined bulk distribution for high-volume clinical and vendor documentation.
signNow targets teams that need enterprise-grade features, broad integrations, and advanced signing controls while retaining accessible pricing and developer tooling.
Preparing a document is simple but limited to basic tags and standard signing order options; no advanced conditional visibility or extensive field types are available for complex forms.
Recipients receive invites and can sign without advanced authentication options; the flow is direct yet may lack multilingual session controls and in-app guidance for complex documents.
Senders can upload and tag documents quickly using the web dashboard, but absent features like automatic field detection and pre-filled templates slow repetitive workflows.
SignaShare does not provide native mobile apps, so field actors must rely on browser-based signing which can reduce reliability and offline signing capability.
Users can share documents within teams and set simple access, but there is no advanced foldering or document grouping for large archives.
Documents can be set to expire which helps limit access after review windows or trial milestones.
An audit trail records actions and timestamps to support evidentiary needs for signed records within contractual disputes.
Reusable templates and basic sender-side drafts exist, though template libraries are not extensive or pre-populated with industry forms.
Native integrations are minimal, requiring API work to connect to LIMS, CRM, or cloud storage systems used by pharma teams.
No native mobile apps or kiosk features are provided, limiting in-person or tablet-based signature capture options.
SignaShare records audit data that supports signer intent and document integrity but lacks many formal certifications listed by enterprise vendors.
For pharmaceutical use, teams typically require explicit HIPAA or CFR Part 11 assurances and regional certifications like eIDAS for EU workflows; SignaShare’s native controls may be insufficient without additional contractual safeguards or third-party controls.
| Criteria | signNow | SignaShare | FormStack | SignRequest | GetAccept |
|---|---|---|---|---|---|
| eSign capability | |||||
| Mobile apps | |||||
| Bulk send | |||||
| HIPAA compliance |
Teams requiring validated, auditable records and HIPAA/CFR support should avoid SignaShare by default
Resulting in a defensible signing process for clinical trials and patient data handling.
If you send thousands of consent or vendor forms, SignaShare’s lack of bulk send hinders throughput
Ensures faster completion and fewer manual follow-ups for high-volume programs.